Heiko Trautmann

Arnold Heller Str. 3
Kiel, SH 24105, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

CD20 expression dynamics in adult B-cell acute lymphoblastic leukemia and impact on anti-CD20 treatment.

CD20 expression dynamics in adult B-cell acute lymphoblastic leukemia and impact on anti-CD20 treatment.

Journal: Journal of hematology & oncology
Published: March 31, 2026

Blinatumomab-driven T-cell activation in αβ and γδ T-cell subsets: insights from in vitro assays.

Blinatumomab-driven T-cell activation in αβ and γδ T-cell subsets: insights from in vitro assays.

Journal: Frontiers in immunology
Published: November 04, 2025

Aggressive Lymphoma after CD19 CAR T-Cell Therapy.

Aggressive Lymphoma after CD19 CAR T-Cell Therapy.

Journal: The New England journal of medicine
Published: November 26, 2024

Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines.

Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines.

Journal: Leukemia
Published: January 13, 2024

Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols.

Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols.

Journal: Leukemia
Published: October 18, 2023

Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia.

Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia.

Journal: Leukemia
Published: July 30, 2023

The KMT2A recombinome of acute leukemias in 2023.

The KMT2A recombinome of acute leukemias in 2023.

Journal: Leukemia
Published: February 08, 2023

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia.

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia.

Journal: Blood
Published: June 01, 2022

UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment.

UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment.

Journal: Leukemia
Published: December 20, 2021

Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods.

Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods.

Journal: Blood advances
Published: November 29, 2021

Comparison of minimal residual disease levels in bone marrow and peripheral blood in adult acute lymphoblastic leukemia.

Comparison of minimal residual disease levels in bone marrow and peripheral blood in adult acute lymphoblastic leukemia.

Journal: Leukemia
Published: March 08, 2019

A modular transcriptome map of mature B cell lymphomas.

A modular transcriptome map of mature B cell lymphomas.

Journal: Genome medicine
Published: November 09, 2018
Showing 1-12 of 23

Last Updated: 09/26/2026